A study published by Egloff et al. revealed an ERα positivity of 95% in 56 head and neck tumors that were evaluated (including 23 OSCC); however, detailed information only for the OSCC cohort was not reported [20]; therefore, a direct comparison is not possible. Here, ESR1 is linked to head and neck neoplasm.